FILE PHOTO: In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn.
Frank Franklin II / AP Photo
FILE PHOTO: In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn.
Frank Franklin II / AP Photo
OxyContin maker Purdue Pharma paid its CEO $9 million and its board chairman nearly $4 million in the 12 months before the company’s bankruptcy filing last month, according to financial documents filed with the bankruptcy court this week.
Five other board members overseeing the private company were paid a combined $3.7 million over that span. In a statement Wednesday, Purdue said the pay reflects the market.
Purdue filed for bankruptcy in September as part of an effort to settle nearly 2,700 lawsuits that seek to hold the company accountable for its role in the nation’s opioid epidemic.
It is trying to reach a settlement that could be worth up to $12 billion over time.
Board chairman Steve Miller, known for helping restructure struggling companies, was brought in last year.
A collection of interviews, photos, and music videos, featuring local musicians who have stopped by the WITF performance studio to share a little discussion and sound. Produced by WITF’s Joe Ulrich.
The days of journalism’s one-way street of simply producing stories for the public have long been over. Now, it’s time to find better ways to interact with you and ensure we meet your high standards of what a credible media organization should be.